Altered Gut Microbiota Related to Inflammatory Responses in Patients With Huntington’s Disease

Gang Du(Capital Medical University), Yue Huang(Yunnan University), Qing Yang(Guangzhou University of Chinese Medicine), Xueying Yu, Weihong Gu(China-Japan Friendship Hospital), Wei Dong(Capital Medical University), Jinghong Ma(Capital Medical University)
Frontiers in Immunology
February 19, 2021
10.3389/fimmu.2020.603594
Cited by 122

Related Papers

Effect of Camrelizumab vs Placebo Added to Chemotherapy on Survival and Progression-Free Survival in Patients With Advanced or Metastatic Esophageal Squamous Cell Carcinoma
|JAMA|2021|821
Sumoylation Promotes the Stability of the DNA Sensor cGAS and the Adaptor STING to Regulate the Kinetics of Response to DNA Virus
|Immunity|2016|378
Impaired FGF signaling contributes to cleft lip and palate
|Proceedings of the National Academy of Sciences|2007|300
Safety, Activity, and Biomarkers of SHR-1210, an Anti-PD-1 Antibody, for Patients with Advanced Esophageal Carcinoma
|Clinical Cancer Research|2018|218
TNF superfamily member TL1A elicits type 2 innate lymphoid cells at mucosal barriers
|Mucosal Immunology|2013|172